All
Results: 97-108 of 44992

CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Southwest Power Pool (SPP) Partners with Hitachi to Develop Advanced AI Solution for Critical Power Transmission Reliability and Flexibility Challenges

Trinasolar releases 2024 Sustainability Report highlighting circular innovation, low-carbon manufacturing, and social impact

FutureCeuticals, Inc. Announces Peer-Reviewed Publication Highlighting Cellular Health and Immune Support Benefits of vitAlign®

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
